🇺🇸 FDA
Patent

US 11511001

Radiolabeled anti-LAG3 antibodies for immuno-PET imaging

granted A61KA61K39/00A61K51/1027

Quick answer

US patent 11511001 (Radiolabeled anti-LAG3 antibodies for immuno-PET imaging) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K39/00, A61K51/1027, A61K51/1039, A61P